• As we discussed in our previous blogs, transitioning to molecular diagnostic PCR testing in other infection categories — particularly as COVID-19 testing slows down — is an important and practical next step in driving revenue growth and in making molecular diagnostic PCR testing the preferred […]

    Continue reading
  • The ability to test a specimen is not only integral in the process of identifying/diagnosing bacterial, fungal, or viral pathogens but — more importantly — it is sometimes the lynchpin in determining how best to treat a patient. That being said, not all labs have […]

    Continue reading
  • Transitioning to or expanding molecular diagnostic testing, also known as polymerase chain reaction (PCR), is a natural step beyond COVID testing because it uses the same type of technology. Molecular diagnostic tests can be used in all infection categories and are designed to identify a […]

    Continue reading